*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Quality by Design – A Tool for Pharmaceutical Industry that Has No Near End

Author: ANUSHKA JOSHI, AISHWARYA RAJPUT, PREETI VERMA, SHOBHIT PRAKASH SRIVASTAVA, UTKARSH SHARMA, SUDHANSHU MISHRA
Abstract: Quality by Design is a trending concept which is widely utilized for the optimization and development of pharmaceutical processes and products worldwide. Currently, the first and foremost concern of the manufacturers and product developers is to provide their customers with the most effective and quality product with the help of the available and most feasible resources. Quality by design concept is based on the ethos that quality is built in a product from the very beginning of the development and not by just testing or inspecting it in the end. This is a systematic and scientific approach that allows the developers to take into consideration all basic factors and variables that may affect the final output and create a robust process and product with the predetermined specifications. A large number of industries are shifting towards risk-based approach like QbD as per their convenience and due to regulatory requirements these days, though along with complete knowledge about the process, basic and advanced knowledge about various facets of this concept is equally important for its successful application. This review briefly describes the elements of quality by design including basic terms like CQAs, QTPP, design space along with advantages of this approach over the traditional approach. It also includes prospects and current challenges and barriers associated with the acceptance of this concept among pharmaceutical industries.
Keyword: Pharmaceutical Science, Quality by design, Optimization, Critical process parameters, Method Development.
DOI: https://doi.org/10.31838/ijpr/2021.13.03.027
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free